Valuation
Is the price right?Insufficient data
Insufficient data: 1 of 3 inputs reported (at least 2 needed). We leave it blank rather than fill the gap with a made-up middle value.
Bringing the fundamentals into focus…
IXHL HealthcareBeta data
Incannex Healthcare Inc.
$2.51+5.25%
Price as of close on Nov 3, 2026 · Financials updated Sep 30, 2026
Basics
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Australia
- Market cap
- 31.4M USD
- Enterprise value
- -26.1M USD
- Full-time employees
- 12
Growth
Is it growing?8/100
Weak
2/3 inputs reported · Partial data
Since last year: ▼ Weaker
- 12-month revenue fell 100.0%
Why
Compare with peers Weaker than most peers on:
- ▼ Revenue growth
Behind the score
Revenue and earnings-per-share growth over one year, and revenue growth over three years.
Earnings per share growthUnavailable
Still loss-making, but the loss per share narrowed33% base weight · Z-score 0.29Sector median: 0.0976 · MAD: 0.29913-year revenue growthUnavailable
Missing · left out of the score · no sector data, so not countedNot counted · remaining weights rescaledSector median: 0.0584 · MAD: 0.0840Revenue growth-100.0%
SEC filings · 12 months to Jun 2026Outlier capped at sector 5th/95th percentile33% base weight · Z-score -4.87Sector median: 0.0609 · MAD: 0.0974Profitability
Does it earn well?Insufficient data
Insufficient data: 1 of 3 inputs reported (at least 2 needed). We leave it blank rather than fill the gap with a made-up middle value.
Risk
Debt, liquidity, price swingsLower
Lower relative risk
3/3 inputs reported · High confidence
Since last year: No major change
Why
Compare with peers Stronger than most peers on:
- ▲ Current ratio
- ▲ Debt / equity
Behind the score
Relative to sector peers: 0 = lower relative risk · 1 = moderate · 2 = higher. Based on leverage, beta and liquidity.
Beta2.83
Yahoo Finance · 5-year monthly beta vs the marketOutlier capped at sector 5th/95th percentile33% base weight · Z-score -4.28Sector median: 0.6250 · MAD: 0.3380Current ratio48.81×
Yahoo FinanceOutlier capped at sector 5th/95th percentile33% base weight · Z-score 11.07Sector median: 2.5860 · MAD: 1.3850Debt / equity<0.01×
Yahoo FinanceOutlier capped at sector 5th/95th percentile33% base weight · Z-score 1.07Sector median: 0.2215 · MAD: 0.2039Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
Questions investors ask about Incannex Healthcare
- Is Incannex Healthcare getting weaker?
- Its latest SEC filing (Sep 25, 2026) got weaker in some ways: 12-month revenue fell 100.0%; share count up 4.8%.
- How is Incannex Healthcare valued vs its peers?
- Insufficient data: 1 of 3 inputs reported (at least 2 needed).
- Is Incannex Healthcare growing?
- More slowly than most of its peers. Growth scores 8/100 against 1,393 healthcare peers. Revenue growth -100.0% vs a peer median of 6.1% (weaker than 100% of peers).Revenue growth -100.0% vs peers 6.1% (weaker than 100% of peers).
- How profitable is Incannex Healthcare?
- Insufficient data: 1 of 3 inputs reported (at least 2 needed).
- How risky is Incannex Healthcare?
- Lower risk relative to 1,393 healthcare peers, judged on debt, liquidity and share-price swings. Current ratio 48.81× vs a peer median of 2.59× (stronger than 95% of peers).Current ratio 48.81× vs peers 2.59× (stronger than 95% of peers). Beta 2.83 vs a peer median of 0.63 (weaker than 100% of peers).Beta 2.83 vs peers 0.63 (weaker than 100% of peers). A relative measure, not a bankruptcy probability.
Latest filing: what changed
Year ended Jun 30, 2026 · filed Sep 25, 2026 · compared with the year ended Jun 30, 2025Got weaker
- 12-month revenue fell 100.0%
- Share count up 4.8% (existing holders diluted)
| Previous year | Latest year | Change | |
|---|---|---|---|
| Revenue (12 months) | 86,000 USD | 0 USD | turned negative |
| Net income (12 months) | −48.4M USD | −19.3M USD | −60.1% |
| Free cash flow (12 months) | −17.7M USD | −12.9M USD | −27.4% |
| Cash | 74.5M USD | 67.7M USD | −9.1% |
| Shares outstanding | 12.0M | 12.5M | +4.8% |
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one year at a time.
Financials
Fiscal years from SEC annual filings · change vs the prior year| Key ratios | FY Jun 2022 | FY Jun 2023 | FY Jun 2024 | FY Jun 2025 | FY Jun 2026 | Change |
|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | -250341.7% | -27661.6% | — | — |
| Net margin | — | — | -153825.0% | -54517.4% | — | — |
| Return on assets (ROA) | -39.3% | -205.2% | -108.3% | -229.3% | -26.4% | ▲ 203 pts |
| Return on equity (ROE) | -60.3% | -234.4% | -164.6% | -350.2% | -28.6% | ▲ 322 pts |
| Free cash flow margin | — | — | -134350.0% | -14559.3% | — | — |
| Current ratio | 18.84× | 9.02× | 2.88× | 2.86× | 48.81× | ▲ >999% |
| Interest coverage | — | — | — | -78.51× | — | — |
IXHL price history
Price history is added with the daily price update and will appear after the next one.